Source: International Congress 2018 – Russian Speaking Programme 2018: Part I



Rating:

Share or cite this content

Citations should be made in the following way:
I. Sermet-Gaudelus (Paris, France). CF: pathogenesis treatment strategies. International Congress 2018 – Russian Speaking Programme 2018: Part I

Member's Comments

No comment yet.

Related content which might interest you: COPD and new treatment options: the role of primary care Source: International Congress 2014 – Primary Care Programme "Management of COPD and other respiratory conditions in clinical practice" Year: 2014 Treatment of interstitial lung diseases: current approaches and future directions Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021 The pathogenesis of IPF: what is the latest paradigm? Source: International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis Year: 2019 Pharmacological options for the treatment of COPD: present and future Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy Year: 2007 COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007 Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy Source: Eur Respir Rev, 31 (163) 210241; 10.1183/16000617.0241-2021 Year: 2022 Practical treatment of CF lung disease Source: ERS course 2015 Year: 2015 Idiopathic pulmonary fibrosis: treatment options in pursuit of evidence-based approaches Source: Eur Respir J 2006; 28: 463-465 Year: 2006 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies Year: 2009 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment Year: 2009 Role of haptogobins genetically determined phenotypes in the development, treatment and prevention pulmonary tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010 PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery Source: Eur Respir Rev 2013; 22: 148-152 Year: 2013 The 2015 guidelines for idiopathic pulmonary fibrosis: an important chapter in the evolution of the management of patients with IPF Source: Eur Respir J 2015; 46: 883-886 Year: 2015 Interactions between bacterial and viral infections during COPD exacerbations: implications for prevention strategies Source: International Congress 2019 – Scientific Year in review Year: 2019